動靜脈畸形市場規模、佔有率和成長分析：按類型、療法、診斷方法、疾病嚴重程度、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球動靜脈畸形市場價值為 21.8 億美元，預計到 2025 年將成長至 23.2 億美元，到 2033 年將成長至 38.1 億美元，在預測期（2026-2033 年）內複合年成長率為 6.4%。

全球動靜脈畸形（AVM）市場可細分為醫療設備、診斷和治療三大領域，所有這些領域都致力於解決可能導致嚴重併發症的異常動靜脈連接問題。先天性血管畸形盛行率的不斷上升以及臨床醫師認知的不斷提高，使得微創治療的需求日益成長。該市場傳統上僅限於外科手術切除，但隨著血管內栓塞等技術的進步，治療選擇顯著增加。液體栓塞劑和影像導引導航等創新技術的普及應用，凸顯了技術進步對醫療專業人員和患者的重要性。此外，完善的醫保報銷系統正在推動市場成長，並鼓勵醫院採用先進的影像設備和導管系統。這種環境促進了製造商和學術機構之間的合作，進一步加強了研發並改善了臨床療效。

全球動靜脈畸形市場成長要素

新一代導管、微彈簧圈和栓塞劑的進步顯著提高了手術精準度，降低了併發症率，並縮短了住院時間。這些因素共同改善了患者預後，並增強了臨床醫師的信心。這些進步正在推動治療機構更廣泛地採用這些技術，拓展了動靜脈畸形的治療選擇，並透過增加手術量和擴大地域覆蓋範圍來推動市場成長。醫療機構正逐步將這些創新技術納入其臨床方案，並輔以旨在建立信任和確保標準化操作規範的培訓計畫。因此，全球動靜脈畸形市場對先進醫療設備的需求持續旺盛。

全球動靜脈畸形市場的限制因素

全球動靜脈畸形市場面臨許多限制因素，阻礙了其成長潛力。先進栓塞材料、灌注支架和影像導引導航系統的高成本，對許多醫療機構，尤其是預算緊張的地區而言，構成了巨大的財務挑戰。這種高昂的價格結構導致醫療機構採取謹慎的籌資策略，從而延緩了新技術的應用，並使其繼續依賴療效欠佳、過時的治療方法。此外，主要經濟體的健保報銷模式往往無法跟上科技的快速發展，導致保險覆蓋範圍有限，病患自付費用增加。這些因素進一步抑制了醫院對這些創新高價值醫療設備的投資意願。

全球動靜脈畸形市場趨勢

全球動靜脈畸形市場正呈現出顯著的融合先進影像技術的趨勢，這凸顯了調查方法的轉變。磁振血管造影術（MRA）和3D旋轉血管造影術等高解析度技術正變得至關重要，它們能夠實現即時容積成像，並提高病變結構的識別率。這項創新不僅減少了侵入性血管造影術的需求，還簡化了微創栓塞病例的選擇流程，從而改善了治療方案的製定，並提高了醫院的運作效率。隨著醫療機構擴大採用整合影像套件，報告顯示，醫護人員對治療的信心增強，病患滿意度也得到提升，這鞏固了先進影像技術在全球區域醫療網路中作為未來市場成長關鍵驅動力的地位。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球動靜脈畸形市場規模：按類型分類

• 腦動靜脈畸形（腦AVM）
• 脊髓動靜脈畸形
• 周邊動靜脈畸形

全球動靜脈畸形市場規模：依治療類型分類

• 血管內栓塞術
• 顯微外科切除
• 立體定位放射放射線手術
• 藥物治療及支持性治療
• 聯合治療

全球動靜脈畸形市場規模：依診斷類型分類

• 磁振造影（MRI）
• 電腦斷層掃描（CT）
• 數位減影血管造影術（DSA）
• 超音波和多普勒成像

全球動靜脈畸形市場規模：依疾病嚴重程度分類

• 未破裂的動靜脈畸形
• 動靜脈畸形破裂

全球動靜脈畸形市場規模：依最終用戶分類

• 醫院
• 神經外科中心
• 神經科專科診所
• 門診手術中心

全球動靜脈畸形市場規模：依通路分類

• 醫院藥房
• 零售藥房
• 專科藥房

全球動靜脈畸形市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson MedTech
• Penumbra, Inc.
• MicroVention, Inc.
• Terumo Corporation
• Balt Group
• Merit Medical Systems, Inc.
• Acandis GmbH
• Integer Holdings Corporation
• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical LLC
• Brainlab AG
• Elekta AB
• Accuray Incorporated
• Canon Medical Systems Corporation
• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• Philips Healthcare（Koninklijke Philips NV）

結論與建議

Global Arteriovenous Malformations Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.32 Billion in 2025 to USD 3.81 Billion by 2033, growing at a CAGR of 6.4% during the forecast period (2026-2033).

The global arteriovenous malformations market is characterized by its segmentation into devices, diagnostics, and therapeutics, addressing abnormal artery-vein connections that can lead to severe complications. A rising prevalence of congenital vascular malformations and enhanced clinician awareness bolster the need for minimally invasive treatment options. Traditionally limited to surgical resection, the market has evolved with advancements like endovascular embolization, which expanded therapeutic avenues significantly. Innovative technologies, including liquid embolic agents and image-guided navigation, are accelerating adoption, demonstrating that technological progress is crucial for practitioners and patients alike. Additionally, improved reimbursement frameworks are fostering market growth, facilitating hospital purchases of advanced imaging and catheter systems. This environment encourages partnerships between manufacturers and academic institutions, further enhancing R&D and clinical outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Arteriovenous Malformations market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Arteriovenous Malformations Market Segments Analysis

Global arteriovenous malformations market is segmented by type, treatment type, diagnosis type, disease severity, end user, distribution channel and region. Based on type, the market is segmented into Cerebral Arteriovenous Malformations (Brain AVMs), Spinal Arteriovenous Malformations and Peripheral Arteriovenous Malformations. Based on treatment type, the market is segmented into Endovascular Embolization, Microsurgical Resection, Stereotactic Radiosurgery, Pharmacological & Supportive Therapy and Combination Therapy. Based on diagnosis type, the market is segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Digital Subtraction Angiography (DSA) and Ultrasound & Doppler Imaging. Based on disease severity, the market is segmented into Unruptured Arteriovenous Malformations and Ruptured Arteriovenous Malformations. Based on end user, the market is segmented into Hospitals, Neurosurgery Centers, Specialty Neurology Clinics and Ambulatory Surgical Centers. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Specialty Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Arteriovenous Malformations Market

The advancements in next-generation catheters, micro-coils, and embolic agents have greatly enhanced precision in procedures, decreased complication rates, and minimized hospital stays, collectively improving patient outcomes and boosting clinician confidence. This progress promotes wider adoption across treatment facilities, thereby broadening the therapeutic options available for arteriovenous malformations and driving market growth through increased procedural volumes and geographical reach. Healthcare providers are progressively incorporating these innovations into their protocols, bolstered by training programs that build trust and ensure a uniform standard of care. As a result, there is a sustained demand for advanced devices within the global arteriovenous malformations market.

Restraints in the Global Arteriovenous Malformations Market

The Global Arteriovenous Malformations market faces several restraints that hinder its growth potential. High costs associated with advanced embolic materials, flow-diverting stents, and image-guided navigation systems pose a substantial financial challenge for many healthcare institutions, particularly in budget-constrained regions. This expensive pricing structure leads to cautious procurement strategies, causing delays in the adoption of new technologies and a reliance on older, less effective treatment options. Additionally, reimbursement models in major economies often do not align with rapid technological progress, resulting in limited coverage and increased out-of-pocket expenses, which further dissuade hospitals from investing in these innovative, high-value devices.

Market Trends of the Global Arteriovenous Malformations Market

The global arteriovenous malformations market is experiencing a significant trend towards advanced imaging integration, highlighting a shift in diagnostic methodologies. High-resolution technologies such as magnetic resonance angiography and 3-D rotational angiography are becoming essential, enabling real-time volumetric visualization that enhances the identification of nidus architecture. This innovation not only reduces the need for invasive angiograms but also streamlines case selection for minimally invasive embolization procedures, thereby improving treatment planning and hospital efficiency. As healthcare facilities increasingly adopt integrated imaging suites, they report elevated procedural confidence and heightened patient satisfaction, solidifying advanced imaging's role as a key driver for future market growth across regional care networks globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Arteriovenous Malformations Market Size by Type & CAGR (2026-2033)

• Market Overview
• Cerebral Arteriovenous Malformations (Brain AVMs)
• Spinal Arteriovenous Malformations
• Peripheral Arteriovenous Malformations

Global Arteriovenous Malformations Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Endovascular Embolization
• Microsurgical Resection
• Stereotactic Radiosurgery
• Pharmacological & Supportive Therapy
• Combination Therapy

Global Arteriovenous Malformations Market Size by Diagnosis Type & CAGR (2026-2033)

• Market Overview
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT) Scan
• Digital Subtraction Angiography (DSA)
• Ultrasound & Doppler Imaging

Global Arteriovenous Malformations Market Size by Disease Severity & CAGR (2026-2033)

• Market Overview
• Unruptured Arteriovenous Malformations
• Ruptured Arteriovenous Malformations

Global Arteriovenous Malformations Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Neurosurgery Centers
• Specialty Neurology Clinics
• Ambulatory Surgical Centers

Global Arteriovenous Malformations Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Specialty Pharmacies

Global Arteriovenous Malformations Market Size & CAGR (2026-2033)

• North America (Type, Treatment Type, Diagnosis Type, Disease Severity, End User, Distribution Channel)
  • US
  • Canada
• Europe (Type, Treatment Type, Diagnosis Type, Disease Severity, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment Type, Diagnosis Type, Disease Severity, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment Type, Diagnosis Type, Disease Severity, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment Type, Diagnosis Type, Disease Severity, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson MedTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVention, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Koninklijke Philips N.V.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations